Rebound of anti-topoisomerase I antibody titres after plasma exchange.
作者信息
Van den Hoogen F H, Boerbooms A M, Van de Putte L B, Verheijen R, Van Venrooij W, Croockewit A J
出版信息
Ann Rheum Dis. 1993 Mar;52(3):246-7. doi: 10.1136/ard.52.3.246.
Abstract
摘要
相似文献
1
Rebound of anti-topoisomerase I antibody titres after plasma exchange.血浆置换后抗拓扑异构酶I抗体滴度的反弹。
Ann Rheum Dis. 1993 Mar;52(3):246-7. doi: 10.1136/ard.52.3.246.
2
[Anti-Scl-70 antibody (anti-topoisomerase I antibody)].[抗Scl-70抗体（抗拓扑异构酶I抗体）]
Nihon Rinsho. 1999 Nov;57 Suppl:425-7.
3
Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).系统性硬化症（硬皮病）中的抗拓扑异构酶-I与临床发现
Isr J Med Sci. 1996 Jul;32(7):537-42.
4
Antibodies to topoisomerase I in sera from patients with scleroderma.硬皮病患者血清中抗拓扑异构酶I抗体。
J Rheumatol Suppl. 1987 Jun;14 Suppl 13:138-40.
5
Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis.系统性硬化症患者拓扑异构酶I免疫显性表位的分析
Mol Biol Rep. 1992 May;16(2):117-23. doi: 10.1007/BF00419757.
6
Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases.系统性硬化症患者肺癌后抗DNA拓扑异构酶I自身抗体反应增强。两例报告。
Arthritis Rheum. 1996 Apr;39(4):686-91. doi: 10.1002/art.1780390423.
7
Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.血清学阴性的迟发性系统性硬化症：一种罕见疾病的罕见表现。
Reumatismo. 2019 Oct 24;71(3):166-170. doi: 10.4081/reumatismo.2019.1170.
8
[Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].[抗拓扑异构酶I抗体（Scl-70）——重组蛋白抗原与天然酶检测的比较研究]
Z Arztl Fortbild (Jena). 1994 Aug;88(7-8):505-11.
9
Correlation between the concentration of serum anti-topoisomerase I autoantibodies and histological and biochemical alterations in the skin of tight skin mice.血清抗拓扑异构酶I自身抗体浓度与紧皮小鼠皮肤组织学及生化改变之间的相关性
Cell Immunol. 1996 Jan 10;167(1):135-40. doi: 10.1006/cimm.1996.0017.
10
A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies.一项关于抗拓扑异构酶I自身抗体的长期纵向同型研究。
Rheumatol Int. 1993;12(6):231-4. doi: 10.1007/BF00301007.
引用本文的文献
1
Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis.治疗性血浆置换治疗系统性硬化症：全面综述与分析
J Scleroderma Relat Disord. 2018 Jun;3(2):132-152. doi: 10.1177/2397198318758606. Epub 2018 Mar 9.
本文引用的文献
1
Plasmapheresis and immunosuppressive drug therapy in scleroderma.硬皮病中的血浆置换和免疫抑制药物治疗。
Arthritis Rheum. 1981 Sep;24(9):1128-36. doi: 10.1002/art.1780240903.
2
Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA.系统性红斑狼疮的治疗性血浆置换。对免疫复合物和抗DNA抗体的影响。
Arthritis Rheum. 1981 Sep;24(9):1113-20. doi: 10.1002/art.1780240901.
3
Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion.血清抗体对抗体形成的调节。II. 通过换血去除特异性抗体。
J Exp Med. 1970 Dec 1;132(6):1279-87. doi: 10.1084/jem.132.6.1279.
4
Regulation of antibody formation by serum antibody. I. Removal of specific antibody by means of immunoadsorption.血清抗体对抗体形成的调节。I. 通过免疫吸附去除特异性抗体。
J Exp Med. 1969 Nov 1;130(5):1175-86. doi: 10.1084/jem.130.5.1175.
5
Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.
Ann Intern Med. 1987 Sep;107(3):344-6. doi: 10.7326/0003-4819-107-2-344.
6
Treatment of systemic sclerosis in 1988.1988年系统性硬化症的治疗
Semin Arthritis Rheum. 1989 Feb;18(3):181-8. doi: 10.1016/0049-0172(89)90060-7.
7
Treatment of progressive systemic sclerosis by plasma exchange: long-term results in 40 patients.血浆置换治疗进行性系统性硬化症：40例患者的长期结果
Int J Artif Organs. 1990 Feb;13(2):125-9.
8
A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis.一种用于检测系统性硬化症患者血清中自身抗体的重组拓扑异构酶I。
Clin Exp Immunol. 1990 Apr;80(1):38-43. doi: 10.1111/j.1365-2249.1990.tb06438.x.
Zotero 插件